Details
Stereochemistry | RACEMIC |
Molecular Formula | C16H21NO4S |
Molecular Weight | 323.407 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCOC1=CC=C(C=C1OCC)C2SC(=O)NC2=O
InChI
InChIKey=CRPGRUONUFDYBG-UHFFFAOYSA-N
InChI=1S/C16H21NO4S/c1-3-5-6-9-21-12-8-7-11(10-13(12)20-4-2)14-15(18)17-16(19)22-14/h7-8,10,14H,3-6,9H2,1-2H3,(H,17,18,19)
DescriptionCurator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/8562538
Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/8562538
RISARESTAT is an aldose reductase inhibitor. It has been shown that topically applied RISARESTAT (CT-112) can penetrate the cornea at sufficient concentrations to inhibit the activity of AR in the lens and can be taken up by the endothelial cells. CT-112 was shown to improve the corneal epithelial barrier function in diabetic patients.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/15722300
0.25% eye drops of RISARESTAT (CT-112) four times a day for 8 weeks.
Route of Administration:
Topical
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/2116955
Curator's Comment: Rat lenses were cultured in a medium containing either 30mM xylose or 30mM glucose. Inhibitory effect of RISARESTAT (CT-112), on the accumulation of sugar alcohols and the concentration of the drug in the lens was measured.
50% inhibition-concentration in the medium was 3.78-5.92 x 10(-7) M for RISARESTAT (CT-112), and the resulting concentration of drug in the lens was 21.19-24.63 nmole/g lens for CT-112.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C471
Created by
admin on Fri Dec 15 16:25:19 GMT 2023 , Edited by admin on Fri Dec 15 16:25:19 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C051003
Created by
admin on Fri Dec 15 16:25:19 GMT 2023 , Edited by admin on Fri Dec 15 16:25:19 GMT 2023
|
PRIMARY | |||
|
79714-31-1
Created by
admin on Fri Dec 15 16:25:19 GMT 2023 , Edited by admin on Fri Dec 15 16:25:19 GMT 2023
|
PRIMARY | |||
|
133264
Created by
admin on Fri Dec 15 16:25:19 GMT 2023 , Edited by admin on Fri Dec 15 16:25:19 GMT 2023
|
PRIMARY | |||
|
DTXSID7048796
Created by
admin on Fri Dec 15 16:25:19 GMT 2023 , Edited by admin on Fri Dec 15 16:25:19 GMT 2023
|
PRIMARY | |||
|
CHEMBL1983865
Created by
admin on Fri Dec 15 16:25:19 GMT 2023 , Edited by admin on Fri Dec 15 16:25:19 GMT 2023
|
PRIMARY | |||
|
6I9DQB98QI
Created by
admin on Fri Dec 15 16:25:19 GMT 2023 , Edited by admin on Fri Dec 15 16:25:19 GMT 2023
|
PRIMARY | |||
|
7936
Created by
admin on Fri Dec 15 16:25:19 GMT 2023 , Edited by admin on Fri Dec 15 16:25:19 GMT 2023
|
PRIMARY | |||
|
C90847
Created by
admin on Fri Dec 15 16:25:19 GMT 2023 , Edited by admin on Fri Dec 15 16:25:19 GMT 2023
|
PRIMARY | |||
|
300000034384
Created by
admin on Fri Dec 15 16:25:19 GMT 2023 , Edited by admin on Fri Dec 15 16:25:19 GMT 2023
|
PRIMARY |
ACTIVE MOIETY